Superior sagittal sinus thrombosis after lumbar puncture in a patient with T-cell lymphoblastic lymphoma: role of the prothrombin G20210A mutation and 4G/4G genotype

Giovanni Caocci; Lara Fenu; Giorgio La Nasa; Francesco Marongiu

doi:10.1055/s-0037-1615581

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 94(04): 881-882
DOI: 10.1055/s-0037-1615581

Case Report

Schattauer GmbH

Superior sagittal sinus thrombosis after lumbar puncture in a patient with T-cell lymphoblastic lymphoma: role of the prothrombin G20210A mutation and 4G/4G genotype

Giovanni Caocci

¹Ematologia-CTMO, Ospedale “R. Binaghi”, ASL 8, Cagliari, Italy

,

Lara Fenu

²Dipartimento di Scienze Mediche Internistiche, Policlinico Universitario, University of Cagliari, Cagliari, Italy

,

Giorgio La Nasa

¹Ematologia-CTMO, Ospedale “R. Binaghi”, ASL 8, Cagliari, Italy

,

Francesco Marongiu

²Dipartimento di Scienze Mediche Internistiche, Policlinico Universitario, University of Cagliari, Cagliari, Italy

› Author Affiliations

Abstract

Full Text

References

References
1 Lockman LA, Mastri A, Priest JR. et al. Dural venous sinus thrombosis in acute lymphoblastic leukemia. Pediatrics 1980; 66: 943-7.
2 Steinherz PG, Miller LP, Ghavimi F. Dural sinus thrombosis in children with acute lymphoblastic leukemia. JAMA 1981; 246: 2837-9.
3 Priest JR, Ramsay NKC, Bennet AJ. et al. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 1982; 100: 990-5.
4 Corso A, Castagnola C, Bernasconi C. Thrombotic event are not exclusive to the remission induction period in patients with acute lymphoblastic leukemia: a report of two cases of cerebral sinus thrombosis. Ann Hematol 1997; 75: 117-9.
5 Meininger V, James JM, Rio B. et al. Dural venous sinus occlusion in hemopathies. Rev Neurol 1985; 141: 228-33.
6 Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol 2004; 251: 11-23.
7 Benzon HT, Iqbal M, Tallman MS. et al. Superior sagittal sinus thrombosis in a patient with postdural puncture headache. Reg Anesth Pain Med 2003; 28: 64-7.
8 Bienfait HP, Gijtenbeek JM, Van Den Bent MJ. et al. Cerebral venous and sinus thrombosis with cerebrospi-882 Case Report nal fluid circulation block after the first methotrexate administration by lumbar puncture. Neuroradiology 2002; 44: 929-32.
9 Canhao P, Batista P, Falcao F. Lumbar puncture and dural sinus thrombosis: a causal or casual association. Cerebrovasc Dis 2004; 19: 53-6.
10 Horlocker TT, Wedel DJ, Benzon H. et al. Regional anesthesia in the anticoagulated patients: defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med 2003; 28: 172-97.
11 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolityc therapy. Chest 2004; 126: 338S-400S.
12 Ruff RL, Dougherty JH. Complications of lumbar puncture following anticoagulation. Stroke 1981; 12: 879-81.
13 Barcellona D, Fenu L, Cauli C. et al. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost. 2003; 90: 1061-4.
14 Bousser MG. Cerebral venous thrombosis. Nothing, heparin, or local thrombolysis?. Stroke 1999; 30: 481-3.
15 Albers GW, Amarenco P, Donald Easton J. et al. Antithrombotic and thrombolytic therapy for ischemic stroke. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 438S-512S.
16 Milhaud D, Heroum C, Charif M. et al. Dural puncture and corticotherapy as risks factors for cerebral venous sinus thrombosis. Eur J Neurol 2000; 7: 123-4.
17 Aidi S, Chaunu MP, Biousse V. et al. Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids. Headache 1999; 39: 559-64.
18 Poort SR, Rosendaal FR, Reitsma PH. et al. A common genetic variation in the 3’ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase venous thrombosis. Blood 1996; 88: 3698-703.
19 Martinelli I, Sacchi E, Landi G. et al. High risk of cerebral-vein thrombosis in carriers of a prothrombingene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 1793-7.
20 Kohler HP, Grant PJ. Plasminogen-Activator-Inhibitor type 1 and coronary artery disease. N Engl J Med 1985; 313: 1157-63.